A rationale for dietary intervention in postmenopausal breast cancer patients: an update

Nutrition and Cancer
L A CohenE L Wynder

Abstract

In 1982, we proposed a large-scale randomized prospective trial to test the hypothesis that decreasing dietary fat intake from 38% to 20% of total calories would increase the disease-free interval and/or five-year survival rate for postmenopausal breast cancer patients. We now review new evidence from epidemiological studies, laboratory animal model studies, and preliminary feasibility trials that has accumulated over the past decade, in support of such a trial, and suggest that a more appropriate dietary goal is a reduction in fat intake to 15% of total calories.

References

Jun 1, 1978·American Journal of Epidemiology·A B MillerM Jain
Sep 15, 1976·International Journal of Cancer. Journal International Du Cancer·A S MorrisonS Yuasa
Mar 1, 1992·American Journal of Public Health·E L WynderS K Ng
Jan 11, 1992·Lancet·K E Hobbs
Jan 1, 1992·Advances in Experimental Medicine and Biology·J T Dwyer
Jan 15, 1992·American Journal of Epidemiology·B S Hulka, B H Margolin
Mar 1, 1992·American Journal of Epidemiology·E L Wynder, S D Stellman
Sep 1, 1991·The American Journal of Clinical Nutrition·D P RoseL E Strong
Apr 3, 1991·Journal of the National Cancer Institute·L A CohenD P Rose
May 1, 1991·Breast Cancer Research and Treatment·D S AllenJ T Murai
May 1, 1991·Breast Cancer Research and Treatment·D Y WangJ Chen
Oct 16, 1991·Journal of the National Cancer Institute·D P RoseC L Meschter
Mar 6, 1991·Journal of the National Cancer Institute·G R HoweA B Miller
Jun 5, 1991·Journal of the National Cancer Institute·Z DjuricS Martino
Oct 1, 1990·Breast Cancer Research and Treatment·P J Goodwin, N F Boyd
Apr 4, 1990·Journal of the National Cancer Institute·G R HoweT Rohan
Jan 1, 1990·Nutrition Reviews·K L Erickson, N E Hubbard
Oct 1, 1990·British Journal of Cancer·T J KeyJ Boreham
Dec 1, 1990·British Journal of Cancer·N F BoydD Tritchler
Sep 1, 1990·Breast Cancer Research and Treatment·L E HolmE Callmer
Jan 1, 1990·Clinical Immunology and Immunopathology·J R HebertJ Y Backlund
Mar 1, 1990·International Journal of Epidemiology·P Van't VeerR J Hermus
Jun 1, 1989·The American Journal of Clinical Nutrition·M N WoodsA Morrill-LaBrode
Nov 15, 1989·International Journal of Cancer. Journal International Du Cancer·J M IscovichJ M Kaldor
Jan 1, 1987·Nutrition and Cancer·C La VecchiaF Parazzini
Feb 15, 1989·Journal of the National Cancer Institute·P TonioloA P Cappa
Sep 1, 1986·Journal of the National Cancer Institute·F LubinB Modan
Sep 1, 1988·American Journal of Epidemiology·T E RohanP A Baghurst
Jan 1, 1986·Nutrition and Cancer·E S Boylan, L A Cohen
Jan 1, 1987·The New England Journal of Medicine·W C WillettF E Speizer
Dec 15, 1986·International Journal of Cancer. Journal International Du Cancer·K KatsouyanniB MacMahon

❮ Previous
Next ❯

Citations

Jan 26, 1996·International Journal of Cancer. Journal International Du Cancer·P CrosignaniF Berrino
Mar 25, 1997·Breast Cancer : the Journal of the Japanese Breast Cancer Society·D P Rose
Dec 1, 1993·Mutation Research·Z Djuric, D Kritschevsky
Jan 1, 1994·Nutrition and Cancer·D P Rose, M A Hatala
Sep 30, 1995·Annals of the New York Academy of Sciences·P Greenwald
Feb 19, 1994·BMJ : British Medical Journal·G M Williams
Sep 1, 1994·Canadian Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquée·L Hoffman-Goetz, J Husted
May 10, 2003·Journal of Women's Health·George L BlackburnRita B Buckley
Nov 1, 1995·International Journal of Food Sciences and Nutrition·A R WalkerS Stelma
Jul 1, 1997·Journal of the American Dietetic Association·E L WynderB L Winters
Apr 1, 2004·Journal of the American Dietetic Association·Barbara L WintersGeorge L Blackburn
Feb 19, 2015·Critical Reviews in Food Science and Nutrition·Sarah F BrennanMarie M Cantwell
Feb 6, 2002·European Journal of Cancer Care·G MaskarinecH Kakai
Nov 1, 1994·Cancer·R T Chlebowski, M Grosvenor
Mar 1, 1994·Journal of Clinical Epidemiology·E L WynderS D Stellman
Dec 1, 1996·Journal of the Royal Society of Health·A R Walker
Nov 1, 1995·Maturitas·D C Knight, J A Eden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Cancer Institute
L E HolmB Nilsson
Journal of Cellular Biochemistry. Supplement
M T RuffinD E Brenner
Japanese Journal of Cancer Research : Gann
Y NomuraY Katsuda
© 2021 Meta ULC. All rights reserved